- Home
- LITB vs UBX Comparison
LITB vs UBX Comparison
Compare LITB & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITB
- UBX
- Stock Information
- Founded
- LITB 2007
- UBX 2009
- Country
- LITB Singapore
- UBX United States
- Employees
- LITB N/A
- UBX N/A
- Industry
- LITB Catalog/Specialty Distribution
- UBX Biotechnology: Pharmaceutical Preparations
- Sector
- LITB Consumer Discretionary
- UBX Health Care
- Exchange
- LITB Nasdaq
- UBX Nasdaq
- Market Cap
- LITB N/A
- UBX 36.9M
- IPO Year
- LITB N/A
- UBX 2018
- Fundamental
- Price
- LITB $1.02
- UBX $1.72
- Analyst Decision
- LITB
- UBX Strong Buy
- Analyst Count
- LITB 0
- UBX 3
- Target Price
- LITB N/A
- UBX $7.33
- AVG Volume (30 Days)
- LITB 21.3K
- UBX 126.2K
- Earning Date
- LITB 03-24-2025
- UBX 03-07-2025
- Dividend Yield
- LITB N/A
- UBX N/A
- EPS Growth
- LITB N/A
- UBX N/A
- EPS
- LITB N/A
- UBX N/A
- Revenue
- LITB $333,093,000.00
- UBX N/A
- Revenue This Year
- LITB N/A
- UBX N/A
- Revenue Next Year
- LITB N/A
- UBX N/A
- P/E Ratio
- LITB N/A
- UBX N/A
- Revenue Growth
- LITB N/A
- UBX N/A
- 52 Week Low
- LITB $0.91
- UBX $0.94
- 52 Week High
- LITB $6.00
- UBX $3.10
- Technical
- Relative Strength Index (RSI)
- LITB 37.97
- UBX 53.37
- Support Level
- LITB $0.92
- UBX $1.53
- Resistance Level
- LITB $1.05
- UBX $1.98
- Average True Range (ATR)
- LITB 0.05
- UBX 0.20
- MACD
- LITB 0.01
- UBX 0.00
- Stochastic Oscillator
- LITB 38.46
- UBX 65.08
About UBX Unity Biotechnology Inc.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.